These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8182514)

  • 21. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism by class I antiarrhythmic drugs of levcromakalim-induced relaxation in isolated rat aorta.
    Cogolludo AL; Perez-Vizcaino F; Tamargo J
    J Pharmacol Exp Ther; 1998 Oct; 287(1):81-6. PubMed ID: 9765325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.
    Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM
    Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection.
    Bolderman RW; Hermans JJ; Maessen JG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1727-31. PubMed ID: 19427276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic administration of nifedipine induces up-regulation of functional calcium channels in rat myocardium.
    Morgan PE; Aiello EA; Chiappe de Cingolani GE; Mattiazzi AR; Cingolani HE
    J Mol Cell Cardiol; 1999 Oct; 31(10):1873-83. PubMed ID: 10525425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of K(ATP) channel modulators in rat cardiac membranes.
    Löffler-Walz C; Quast U
    Br J Pharmacol; 1998 Apr; 123(7):1395-402. PubMed ID: 9579735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radioreceptor assay: principles and applications to pharmacology].
    Perret G; Simon P
    J Pharmacol; 1984; 15(3):265-86. PubMed ID: 6149335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Unwanted drug interaction between anti-arrhythmic drugs and drugs used for heart failure].
    Jaźwińska-Tarnawska E; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2000 Sep; 9(51):614-7. PubMed ID: 11126988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RSD1000: a novel antiarrhythmic agent with increased potency under acidic and high-potassium conditions.
    Yong SL; Xu R; McLarnon JG; Zolotoy AB; Beatch GN; Walker MJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):236-44. PubMed ID: 10087010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of the one-ring open metabolites of the cardioprotective drug dexrazoxane to its active metal-chelating form in the rat.
    Schroeder PE; Hasinoff BB
    Drug Metab Dispos; 2005 Sep; 33(9):1367-72. PubMed ID: 15980099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation.
    Delaney J; Hodson MP; Thakkar H; Connor SC; Sweatman BC; Kenny SP; McGill PJ; Holder JC; Hutton KA; Haselden JN; Waterfield CJ
    Arch Toxicol; 2005 Apr; 79(4):208-23. PubMed ID: 15838709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
    Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
    Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone derivatives that bind to the digitalis receptor: structure--activity relationships.
    Kim RS; LaBella FS; Zunza H; Zunza F; Templeton JF
    Mol Pharmacol; 1980 Nov; 18(3):402-5. PubMed ID: 7464804
    [No Abstract]   [Full Text] [Related]  

  • 39. Limitations of the sodium fusion assay for fluorinated metabolites.
    Ivanetich KM; Bradshaw JJ; Brittain T
    Anesth Analg; 1982 Sep; 61(9):786-7. PubMed ID: 7201760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor assays in the clinical laboratory.
    Soldin SJ
    Clin Biochem; 1996 Oct; 29(5):439-44. PubMed ID: 8884064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.